[Benign and malignant monoclonal hypergammaglobulinemia (gammopathy)].
D000367:Age Factors; D000917:Antibody Formation; D001167:Arteritis / Q000276:immunology; D001536:Bence Jones Protein / Q000032:analysis; D001796:Blood Protein Disorders / Q000145:classification*; D001797:Blood Protein Electrophoresis; D002999:Clone Cells / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006942:Hypergammaglobulinemia / Q000145:classification / Q000378:metabolism; D007120:Immunochemistry; D007945:Leukemia, Lymphoid / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D008259:Macroglobulins / Q000378:metabolism; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology / Q000401:mortality; D010950:Plasma Cells / Q000276:immunology; D009626:Terminology as Topic; D008258:Waldenstrom Macroglobulinemia / Q000276:immunology / Q000401:mortality; D005719:gamma-Globulins / Q000096:biosynthesis
D008259:Macroglobulins; D005719:gamma-Globulins; D003520:Cyclophosphamide; D001536:Bence Jones Protein; D008558:Melphalan
Benigne und maligne monoklonale Hypergammaglobulinämie (Gammapathie)